Background: Since the emergence of the novel coronavirus, the front line soldiers during this pandemic are the healthcare professionals because of their direct association with COVID19 patients. In the management of such patients, nurses play a significant role through proper care and preventive measures. Due to its contagious nature, fatality, and no proper medicine, it is a risk to the health and life of nurses and has an impact on their psychological health. The aim of the current study was to assess the knowledge, attitude, practices, and anxiety levels of the frontline nurses. Methods: It was an online questionnaire-based cross-sectional survey targeting only those nurses involved in the management of COVID-19 patients from different hospitals of Karachi, Pakistan. SPSS 21 was used for data analysis. Descriptive analysis, Chi-Square, and t-tests were applied. P-value <0.05 was considered significant. Results: Data of 78 nurses were analyzed. We observed that nurses possess good knowledge about COVID-19, its sources, symptoms, and routes of transmission of the Virus, etc. The knowledge mean score was calculated at 14.67 ± 3.36. Health Department /Hospital and social media are the main sources of information regarding COVID-19. We investigated that 92.3% of the nurses had mild to severe anxiety and anxiety levels are significantly higher among females (P<0.05). Conclusion:-We concluded that the nurses performing their duties with COVID-19 positive patients have good knowledge and attitude. But their anxiety levels are high. Psychological interventions along with training should be given.
OBJECTIVE: The objective of this study is to evaluate the level of anxiety and fear among Pakistani dentists due to COVID-19. METHODOLOGY: Data of 386 dentists evaluated who responded to the questionnaire sent via social media. Fear of coronavirus scale (FCV-19S) was used for evaluation of fear among Pakistani dentists. Data was entered and analyzed using SPSS version 21. One way ANOVA, chi-square and independent t-test were used for statistical analysis. P-value <0.05 was considered as significant. RESULTS: The overall mean FCV-19S score was 26.22 ± 4.907, which is on the higher end. Females showed higher fear scores as compared to males (p<0.001). A statistically significant difference between the scores of General Dental Practitioners (GDP) and specialists was also observed (p<0.001), Statistically, a significant difference was observed between all 4 age groups of dentists, young and elderly dentists demonstrating higher scores (F (3,382) = 8.618, p< 0.001). CONCLUSION: We conclude that due to the current COVID-19 crisis, majority of the dentists of Pakistan are afraid and among them, females, GDPs, young and elderly dentists are found to be more anxious and have a greater fear of getting infected by coronavirus during COVID 19 Pandemic. KEYWORDS: Anxiety, Fear, Pakistani, Dentist, COVID-19 HOW TO CITE: Majeed MM, Saleem Z, Sarwar H, Ramzan Z, Iqbal SN, Naeem MM. The psychology of coronavirus fear: Are dentists of pakistan suffering from corona-phobia?. J Pak Dent Assoc 2021;30(1):1-6.
Objective Diabetes distress typically causes depressive symptoms; common comorbidity of diabetes unpleasantly affects patients’ medical and psychological functions. Psychotherapeutic interventions are effective treatments to treat depressive symptoms and to improve the quality of life in many chronic diseases including diabetes. The present study investigated the efficacy of cognitive behavior therapy (CBT) to treat depressive symptoms in patients with type 2 diabetes mellitus (T2DM) using experimental and waitlist control conditions. Materials and Methods A total of 130 diagnosed patients with T2DM were taken from outdoor patients services of different hospitals in Faisalabad. Ninety patients met the eligibility criteria and were randomly assigned to experimental (n = 45) and waitlist control (n = 45) conditions. All the patients completed clinical interviews and assessment measures at pre-and post-assessment stages (16 weeks intervals). Medical consultants at the respective hospitals diagnosed the patients on the base of their medical reports and then referred those patients to us. Then we used different scales to assess primary and secondary outcomes: Diabetes Distress Scale (DDS) and Patient Health Questionnaire (PHQ) to assess primary outcomes, and a Short Health Anxiety Inventory (SHAI), a Revised Version of the Diabetes Quality of Life Questionnaire (DQLQ), and a General Medication Adherence Scale (GMAS) were used to investigate secondary outcomes. Repeated measure ANOVA was used to analyze the results. Results The findings indicated that patients who received CBT got a significant reduction in their diabetes distress F(1,60) = 222.710, P < 0.001, η2 = .788), depressive symptoms F(1,60) = 94.436, P < 0.001, η2 = .611), health anxiety F(1,60) = 201.915, P < .0.001, η2 = 771), and a significant improvement in their quality of life F(1,60) = 83.352, P < 0.001, η2 = .581), treatment adherence F(1,60) = 67.579, P < 0.001, η2 = .566) and physical activity schedule F(1,60) = 164.245, P < .0.001, η2 = .736 as compared to the patients in waitlist control condition. Conclusion It is concluded that cognitive behavior therapy is an effective and promising intervention for depressive symptoms, diabetes distress, and health anxiety which also helps the person to promote quality of life, treatment adherence and physical activity.
Objective Individuals living with HIV/AIDs are at a high risk of many problems like depression, stigma, quality of life, decreased adherence to treatment, and lack of social support. The present study aimed to investigate the impact of brief-cognitive behavior therapy (B-CBT) on reducing depression and stigma and improving treatment adherence, quality of life, and social support among patients with HIV/AIDS attending antiretroviral therapy (ART). Materials and methods This randomized clinical trial was conducted at ART Clinic in the Tehsil Headquarters Hospital Shahkot Nankana Sahib from July 2021 to October 2021. After baseline screening, 126 patients met the eligibility criteria and 63 were allocated to the experimental group (EXPg = 63) and 63 to waitlist-control group (WLCg = 63). Participants’ age range was from 20 to 55 years. Participants who were taking ART treatment were enrolled for the CBT treatment. Before this, all the participants completed a baseline assessment to ensure a level of severity and diagnosis. A total of eight CBT based therapeutic sessions were conducted individually with EXPg. To assess the outcomes among patients receiving ART, we used Demographic form, Patient health questionnaire, HIV stigma scale, General medication adherence scale, Multidimensional scale of perceived social support, and WHOQOL BREF scale. Results Findings suggest that B-CBT significantly reduced the level of depression (i.e. F (1, 78) = 101.38, p < .000, η2 = .599), and social stigma (i.e. F (1, 78) = 208.47, p < .000, η2 = .787) among patients with HIV/AIDS. Furthermore, CBT substantially improved the level of adherence to treatment (i.e. F(1,78) = 24.75, p < .000, η2 = .503), social support (i.e. F (1, 78) = 128.33, p < .000, η2 = .606), and quality of life (i.e. F (1, 78) = 373.39, p < .000, η2 = .837) among patients with HIV/AIDS. Significant mean difference M(SD) on PHQ at post-analysis in the EXPg vs. WLCg was seen 1.22(0.47) vs. 2.30(0.68) and similarly, on MPSS at a post-analysis in the EXPg vs. WLCg 2.85(0.36) vs. 1.70(0.51) which indicates sound therapeutic outcomes. Conclusions Cognitive behavioral therapy effectively decreases the level of depression and stigma and enhances the level of social support, quality of life, and adherence to treatment among HIV/AIDS patients. It is concluded that cognitive behavior therapy is an effective treatment approach for patients with HIV/AIDS. Trial registration Thai clinical trial registry (i.e. TCTR = TCTR20210702002).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.